malondialdehyde has been researched along with gliclazide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H | 1 |
| Alper, G; Caglayan, O; Duman, E; Irer, S; Yilmaz, C | 1 |
| Araújo Júnior, RF; Araújo, AA; Brito, GAC; Guedes, PMM; Hiyari, S; Medeiros, CACX; Morais, HB; Pirih, FQ | 1 |
| Abdelkader, NF; Badawi, MA; Eitah, HE; Gamaleldin, AA; Kenawy, SA; Maklad, YA | 1 |
| Hosseinimehr, SJ; Karimpour Malekshah, A; Mirzaei, M; Taghizadeh, F; Talebpour Amiri, F; Zargari, M | 1 |
| Chen, HM; Feng, XX; Huang, N; Kang, XH; Kong, SZ; Li, WJ; Luo, H; Su, ZR; Yu, XT; Zhang, X | 1 |
1 trial(s) available for malondialdehyde and gliclazide
| Article | Year |
|---|---|
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide.
Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances | 2004 |
5 other study(ies) available for malondialdehyde and gliclazide
| Article | Year |
|---|---|
Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Animals; Antioxidants; Blood Glucose; Body Weight; Deoxyguanosine; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA Damage; Gliclazide; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidants; Oxidative Stress; Rats; Rats, Inbred Strains; Selegiline; Superoxide Dismutase; Vitamin A; Vitamin E | 2005 |
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Cathepsin K; Fluorescent Antibody Technique; Gingiva; Gliclazide; Glutathione; Immunohistochemistry; Interleukin-1beta; Macrophage Migration-Inhibitory Factors; Male; Malondialdehyde; Matrix Metalloproteinase 2; Neutrophils; Oxidative Stress; Periodontitis; Peroxidase; Random Allocation; RANK Ligand; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; X-Ray Microtomography | 2019 |
New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
Topics: Animals; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Gliclazide; Glutathione; Hypoglycemic Agents; Inflammation; Insulin; Islets of Langerhans; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Pancreas; Quercetin; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2020 |
Alleviation of cisplatin-induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase-3 activity.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Aspartate Aminotransferases; Caspase 3; Chemical and Drug Induced Liver Injury; Cisplatin; Gliclazide; Glutathione; Liver; Male; Malondialdehyde; Mice, Inbred BALB C; Oxidative Stress | 2021 |
The protective effect of 18β-Glycyrrhetinic acid against UV irradiation induced photoaging in mice.
Topics: Animals; Elasticity; Female; Glutathione Peroxidase; Glycyrrhetinic Acid; Malondialdehyde; Matrix Metalloproteinase 3; Mice; Radiation-Protective Agents; Skin; Skin Aging; Superoxide Dismutase; Ultraviolet Rays | 2015 |